| Janssen-Cilag AG - Rybrevant SC 2400 mg/15 ml, Injektionslösung | | 69839 | | 03 | | Rybrevant SC 2400 mg/15 ml | | Injektionslösung | | L01FX18 | | Amivantamab | | 30.09.2026 | | |
| | Composition | | amivantamabum 2400 mg, hyaluronidasum humanum ADNr, natrii acetas trihydricus, acidum aceticum glaciale, saccharum, polysorbatum 80 9 mg, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 9.28 mg. | | Packungsbestandteile | | Injection solution | | | | | | Active Agent | Dose |
|---|
| Amivantamabum | 2400mg / 15ml |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Dinatrii Edetas | | | Hyaluronidasum Humanum Adnr | | | Methionine | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | 9mg / 15ml | | Saccharum | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | | | | A | | Yes |
|
|
